Home
Octagon Capital Advisors reported a 3.3% stake in Taysha Gene Therapies TSHA · 9,067,500 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.3%
- Last report
- 5.1% · filed 25/02/05
- Shares held
- 9,067,500 sh
- Class
- Common Stock, $0.00001 par value
- Holder
- Octagon Capital Advisors
- Event date
- 25/09/30
- Filed
- 25/11/14
3.3% stake · below 5%
- Stake
- 3.3%
- Last report
- 5.1%
- Since last report
- −1.8pp
Taysha Gene Therapies trades, last 26 weeks
What else happened in Taysha Gene Therapies around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Octagon Capital Advisors's other 5% stake reports
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.3% stake
3,050,000 sh
3.3% stake
Filed 07/31
- Octagon Capital Advisors
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
5.7% stake
5,250,000 sh
5.7% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
0% stake
0 sh
0% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeGossamer Bio
5% stakeGossamer Bio
GOSS
3.8% stake
8,976,054 sh
3.8% stake
Filed 05/14
- Octagon Capital Advisors
5% stakeDianthus Therapeutics
5% stakeDianthus Therapeutics
DNTH
3.6% stake
1,946,667 sh
3.6% stake
Filed 05/14
